20.69
price down icon3.63%   -0.78
pre-market  Vorhandelsmarkt:  20.68   -0.01   -0.05%
loading

Apellis Pharmaceuticals Inc Aktie (APLS) Neueste Nachrichten

pulisher
05:55 AM

How moving averages guide Apellis Pharmaceuticals Inc. trading2025 Stock Rankings & Real-Time Chart Pattern Alerts - newser.com

05:55 AM
pulisher
05:31 AM

Can Apellis Pharmaceuticals Inc. stock resist sector downturnsJuly 2025 Volume & Comprehensive Market Scan Reports - newser.com

05:31 AM
pulisher
04:35 AM

Will Apellis Pharmaceuticals Inc. see short term momentumTrade Performance Summary & Target Return Focused Stock Picks - newser.com

04:35 AM
pulisher
Nov 03, 2025

Apellis Pharmaceuticals (APLS): Mizuho Adjusts Price Target and Rating Update | APLS Stock News - GuruFocus

Nov 03, 2025
pulisher
Nov 03, 2025

Risk vs reward if holding onto Apellis Pharmaceuticals Inc.Portfolio Value Report & Safe Swing Trade Setups - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using AI based signals to follow Apellis Pharmaceuticals Inc.July 2025 Decliners & Smart Money Movement Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Real time scanner hits for Apellis Pharmaceuticals Inc. explainedJuly 2025 Market Mood & Safe Entry Trade Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Apellis Pharmaceuticals Inc. stock attractive for income investorsWeekly Market Summary & Expert Approved Momentum Ideas - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Apellis Pharmaceuticals Inc. (1JK) stock could rally stronglyMarket Movement Recap & AI Driven Stock Price Forecasts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will breakout in Apellis Pharmaceuticals Inc. lead to full recoveryJuly 2025 Big Picture & AI Based Buy/Sell Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will a bounce in Apellis Pharmaceuticals Inc. offer an exitWeekly Market Summary & Safe Capital Allocation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How to build a dashboard for Apellis Pharmaceuticals Inc. stockTrade Performance Summary & Smart Swing Trading Techniques - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

How interest rate cuts could boost Apellis Pharmaceuticals Inc. stock2025 Volatility Report & Safe Capital Growth Stock Tips - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Apellis Pharmaceuticals Inc. stock is rated strong buy2025 Price Momentum & AI Enhanced Trading Signals - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Apellis Pharmaceuticals Inc. (1JK) stock rise with strong economyWeekly Investment Recap & Community Verified Trade Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Apellis Pharmaceuticals Inc. stock maintain dividend yieldEarnings Overview Report & Daily Stock Trend Reports - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can Apellis Pharmaceuticals Inc. (1JK) stock survive global slowdownEarnings Performance Report & Verified Short-Term Plans - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Does Apellis Pharmaceuticals Inc. (1JK) stock trade below intrinsic valueEarnings Recap Summary & Weekly High Return Stock Opportunities - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Regression analysis insights on Apellis Pharmaceuticals Inc. performanceQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Apellis Stock Down Despite Q3 Earnings and Revenues Beat Estimates - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Apellis Pharmaceuticals Hits Day Low of $20.66 Amid Price Pressure - Markets Mojo

Nov 02, 2025
pulisher
Nov 02, 2025

Brighton Jones LLC Buys Shares of 16,539 Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

Apellis Pharmaceuticals Inc. recovery potential after sell off2025 Market WrapUp & Verified Momentum Stock Watchlist - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Apellis Pharmaceuticals Inc. stock prediction for this weekWeekly Trend Recap & Smart Money Movement Tracker - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why retail investors favor Apellis Pharmaceuticals Inc. stockJuly 2025 Selloffs & Weekly High Return Stock Forecasts - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Citigroup Issues Pessimistic Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Lowered to $45.00 at TD Cowen - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Price Target Cut to $45.00 by Analysts at HC Wainwright - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Robert W. Baird Issues Positive Forecast for Apellis Pharmaceuticals (NASDAQ:APLS) Stock Price - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Q3 2025 Earnings Call Transcript - Insider Monkey

Nov 01, 2025
pulisher
Nov 01, 2025

How sentiment analysis helps forecast Apellis Pharmaceuticals Inc.July 2025 Movers & Weekly High Return Opportunities - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Jennison Associates LLC Raises Holdings in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Y Intercept Hong Kong Ltd Has $2.84 Million Stock Position in Apellis Pharmaceuticals, Inc. $APLS - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

Apellis Pharmaceuticals, Inc. $APLS Shares Sold by AlphaQuest LLC - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

How Apellis Pharmaceuticals Inc. stock performs in weak economyJuly 2025 Breakouts & Verified Chart Pattern Signals - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

APLS: Citigroup Lowers Price Target Amidst Maintained Buy Rating - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Shares Gap DownTime to Sell? - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Apellis Pharmaceuticals Inc Stock Analysis and ForecastDividend Cut Warnings & Free Wealth Planning Blueprints - earlytimes.in

Oct 31, 2025
pulisher
Oct 31, 2025

APLS Analyst Rating Update: TD Cowen Adjusts Price Target | APLS Stock News - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

Apellis Pharmaceuticals (NASDAQ:APLS) Releases Quarterly Earnings Results, Beats Estimates By $0.64 EPS - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Apellis Pharmaceuticals, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:APLS) 2025-10-31 - Seeking Alpha

Oct 31, 2025
pulisher
Oct 31, 2025

Apellis Pharmaceuticals (APLS): Forecast 13% Annual Revenue Growth, Shares Trade at Deep Discount Heading Into Earnings - Yahoo Finance

Oct 31, 2025
pulisher
Oct 31, 2025

APLS Stock: Baird Raises Price Target to $52, Maintains Outperfo - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

APLS: HC Wainwright & Co. Lowers Price Target, Maintains 'Buy' R - GuruFocus

Oct 31, 2025
pulisher
Oct 31, 2025

APLS: HC Wainwright & Co. Lowers Price Target, Maintains 'Buy' Rating | APLS Stock News - GuruFocus

Oct 31, 2025
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):